These results not only clarified how ZKSCAN3 facilitates cervical cancer advancement through the coordination of proliferation, metastasis, and alterations in the tumor microenvironment, but also offered experimental support for its use as a prognostic biomarker and potential therapeutic target [77]. This evidence concerns the gene ZKSCAN3 and cervical carcinoma.